Meeting
2020 ASCO Virtual Scientific Program
Evaluation of a computational decision support system for molecularly targeted treatment planning by the clinical outcome data of the randomized trial SHIVA01.
Authors
Anna Dirner
Oncompass Medicine Hungary Ltd, Budapest, Hungary
Anna Dirner , Robert Doczi , Peter Filotas , Barbara Vodicska , Edit Varkondi , Dora Tihanyi , Célia Dupain , Nicolas Servant , Maud Kamal , Csilla Hegedűs , Richárd Schwab , Christophe Le Tourneau , Istvan T. Valyi-Nagy , István Peták
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Other Developmental Therapeutics
Citation
J Clin Oncol 38: 2020 (suppl; abstr 3642)
DOI
10.1200/JCO.2020.38.15_suppl.3642
Abstract #
3642
Poster Bd #
372
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Molecular profiling in gynecologic cancer and matched targeted therapy: A step toward improving personalized medicine.
First Author: Ana C. Garrido-Castro
Poster
2024 ASCO Annual Meeting
Precision oncology for rare gynecologic malignancies: Integrating molecular tumor boards and real-time treatment matching.
First Author: Brooke Grant
Poster
2022 ASCO Quality Care Symposium
Implementation of a virtual, on-demand, molecular tumor board at a large, multi-clinic, community oncology practice.
First Author: Andrew Jacob McKenzie
Poster
2022 ASCO Annual Meeting
Patient-derived organoids to predict the drug response in locally advanced or metastatic lung cancer: A real-world study.
First Author: Chan-Yuan Zhang